NCT03473756
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03473756
Title Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma (FORT-2)
Acronym FORT-2
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Bayer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | AUT

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85724 United States Details
UChicago Medicine Comprehensive Cancer Center - Hyde Park Chicago Illinois 60637 United States Details
Barbara Ann Karmanos Cancer Institute - Detroit Headquarters Detroit Michigan 48201 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Ordensklinikum Linz GmbH Elisabethinen Linz Upper Austria 4020 Austria Details
Krankenhaus der Barmherzigen Brüder Vienna Vienna 1020 Austria Details
Uniklinikum Salzburg - Landeskrankenhaus Salzburg 5020 Austria Details
Universitätsklinikum AKH Wien Vienna 1090 Austria Details
Institut Bergonie - Unicancer Nouvelle Aquitaine Bordeaux 33076 France Details
Centre Oscar Lambret - Lille Lille 59020 France Details
Institut de Cancérologie de l'Ouest - Saint Herblain Saint-Herblain 44800 France Details
Universitätsklinikum Köln Cologne North Rhine-Westphalia 50937 Germany Details
Universitätsklinikum Essen Essen North Rhine-Westphalia 45147 Germany Details
Universitätsmedizin der Johannes Gutenberg Universität Mainz Mainz Rhineland-Palatinate 55101 Germany Details
Azienda Ospedaliero Universitaria di Modena Modena Emilia-Romagna 41100 Italy Details
Fondazione IRCCS Istituto Nazionale dei Tumori Milan Lombardy 20133 Italy Details
Istituto Europeo di Oncologia s.r.l - Sviluppo di nuovi farmaci per Terapie Innovative Milan Lombardy 20141 Italy Details
Istituto Oncologico Veneto Padua Veneto 35128 Italy Details
A.O.U.I. Verona Verona Veneto 37134 Italy Details
National Cancer Center Hospital East Kashiwa Chiba 277-8577 Japan Details
National Hospital Organization Shikoku Cancer Center Matsuyama Ehime 791-0280 Japan Details
University of Tsukuba Hospital Tsukuba Ibaraki 305-8576 Japan Details
The Cancer Institute Hospital of JFCR Koto-ku Tokyo 135-8550 Japan Details
Severance Hospital, Yonsei University Health System Seoul Seoul Teugbyeolsi 03722 South Korea Details
Asan Medical Center Seoul Seoul Teugbyeolsi 05505 South Korea Details
Samsung Medical Center Seoul 06351 South Korea Details
Ciutat Sanitaria i Universitaria de la Vall d'Hebron Barcelona 08035 Spain Details
Hospital Clínic i Provincial de Barcelona Barcelona 8036 Spain Details
Hospital Ramón y Cajal | Oncología Madrid 28034 Spain Details
Hospital General Universitario de Valencia Valencia 46014 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field